The Risks of Medical Innovation
Risk Perception and Assessment in Historical Context
Herausgeber: Schlich, Thomas; Tröhler, Ulrich
The Risks of Medical Innovation
Risk Perception and Assessment in Historical Context
Herausgeber: Schlich, Thomas; Tröhler, Ulrich
- Broschiertes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Presenting a new way of thinking about the risks of medical innovation, this volume considers the issues from a social historical perspective, and studies specific cases in their respective contexts.
Andere Kunden interessierten sich auch für
- National Research CouncilMedical Innovation in the Changing Healthcare Marketplace32,99 €
- National Research CouncilAssessing the Medical Risks of Human Oocyte Donation for Stem Cell Research45,99 €
- Shigehisa KuriyamaThe Expressiveness of the Body and the Divergence of Greek and Chinese Medicine22,99 €
- F. González-CrussiA Short History of Medicine18,99 €
- W. Terry HowellHealthcare Is Killing Us: The Power of Disruptive Innovation to Create a System that Cares More and Costs Less27,99 €
- Centers of Disease ControlFrom Innovation to Implementation - Ehealth in the Who European Region (2016)40,99 €
- Proceedings of the 2nd International Conference of Health Innovation and Technology (ICHIT 2022)55,99 €
-
-
-
Presenting a new way of thinking about the risks of medical innovation, this volume considers the issues from a social historical perspective, and studies specific cases in their respective contexts.
Produktdetails
- Produktdetails
- Verlag: Taylor & Francis
- Seitenzahl: 304
- Erscheinungstermin: 9. Februar 2015
- Englisch
- Abmessung: 234mm x 156mm x 17mm
- Gewicht: 435g
- ISBN-13: 9781138867949
- ISBN-10: 1138867942
- Artikelnr.: 42091039
- Verlag: Taylor & Francis
- Seitenzahl: 304
- Erscheinungstermin: 9. Februar 2015
- Englisch
- Abmessung: 234mm x 156mm x 17mm
- Gewicht: 435g
- ISBN-13: 9781138867949
- ISBN-10: 1138867942
- Artikelnr.: 42091039
Thomas Schlich is Canada Research Chair in the History of Medicine at the Department of Social Studies of Medicine at McGill University, Canada. Ulrich Tröhler heads the Institute for the History of Medicine of the University of Freiburg, Germany.
Preface. Risk and Medical Innovation: A Historical Perspective. To Assess
and to Improve: Practitioners? Approaches to Doubts Linked with Medical
Innovations 1720-1920. Anaesthesia and the Evaluation of Surgical Risk in
Mid-Nineteenth Century Britain. Redemption, Danger, and Risk: The History
of Anti-Bacterial Chemotherapy and the Transformation of Tuberculin. As
Safe as Milk or Sugar Water?: Perceptions of Risks and Benefits of the BCG
Vaccine in the 1920s and 1930s in France and Germany. From Danger to Risk:
The Perception and Regulation of X-Rays in Switzerland 1896-1970. The
Population as Patient: Alice Stewart and the Controversy over Low-Level
Radiation in the 1950s. To Treat or Not to Treat: Drug Research and the
Changing Nature of Essential Hypertension. Hormones at Risk: Cancer and the
Medical Uses of Industrially-Produced. Sex Steroids in Germany, 1930-1960.
Assessment and Medical Authority in Operative Fracture Care in the 1960 and
1970s. Assessing the Risk and Safety of the Pill: Maternal Mortality and
the Pill. Addressing Uncertainties: The Conceptualisation of Brain Death in
Switzerland 1960-2000. Risk on Trial. The Interaction of Innovation and
Risk in Cancer Clinical Trials. BioRisk: Interleukin-2 from Laboratory to
Market in the United States and Germany. The Redemption of Thalidomide:
Standardizing the Risk of Birth Defects
and to Improve: Practitioners? Approaches to Doubts Linked with Medical
Innovations 1720-1920. Anaesthesia and the Evaluation of Surgical Risk in
Mid-Nineteenth Century Britain. Redemption, Danger, and Risk: The History
of Anti-Bacterial Chemotherapy and the Transformation of Tuberculin. As
Safe as Milk or Sugar Water?: Perceptions of Risks and Benefits of the BCG
Vaccine in the 1920s and 1930s in France and Germany. From Danger to Risk:
The Perception and Regulation of X-Rays in Switzerland 1896-1970. The
Population as Patient: Alice Stewart and the Controversy over Low-Level
Radiation in the 1950s. To Treat or Not to Treat: Drug Research and the
Changing Nature of Essential Hypertension. Hormones at Risk: Cancer and the
Medical Uses of Industrially-Produced. Sex Steroids in Germany, 1930-1960.
Assessment and Medical Authority in Operative Fracture Care in the 1960 and
1970s. Assessing the Risk and Safety of the Pill: Maternal Mortality and
the Pill. Addressing Uncertainties: The Conceptualisation of Brain Death in
Switzerland 1960-2000. Risk on Trial. The Interaction of Innovation and
Risk in Cancer Clinical Trials. BioRisk: Interleukin-2 from Laboratory to
Market in the United States and Germany. The Redemption of Thalidomide:
Standardizing the Risk of Birth Defects
Preface. Risk and Medical Innovation: A Historical Perspective. To Assess
and to Improve: Practitioners? Approaches to Doubts Linked with Medical
Innovations 1720-1920. Anaesthesia and the Evaluation of Surgical Risk in
Mid-Nineteenth Century Britain. Redemption, Danger, and Risk: The History
of Anti-Bacterial Chemotherapy and the Transformation of Tuberculin. As
Safe as Milk or Sugar Water?: Perceptions of Risks and Benefits of the BCG
Vaccine in the 1920s and 1930s in France and Germany. From Danger to Risk:
The Perception and Regulation of X-Rays in Switzerland 1896-1970. The
Population as Patient: Alice Stewart and the Controversy over Low-Level
Radiation in the 1950s. To Treat or Not to Treat: Drug Research and the
Changing Nature of Essential Hypertension. Hormones at Risk: Cancer and the
Medical Uses of Industrially-Produced. Sex Steroids in Germany, 1930-1960.
Assessment and Medical Authority in Operative Fracture Care in the 1960 and
1970s. Assessing the Risk and Safety of the Pill: Maternal Mortality and
the Pill. Addressing Uncertainties: The Conceptualisation of Brain Death in
Switzerland 1960-2000. Risk on Trial. The Interaction of Innovation and
Risk in Cancer Clinical Trials. BioRisk: Interleukin-2 from Laboratory to
Market in the United States and Germany. The Redemption of Thalidomide:
Standardizing the Risk of Birth Defects
and to Improve: Practitioners? Approaches to Doubts Linked with Medical
Innovations 1720-1920. Anaesthesia and the Evaluation of Surgical Risk in
Mid-Nineteenth Century Britain. Redemption, Danger, and Risk: The History
of Anti-Bacterial Chemotherapy and the Transformation of Tuberculin. As
Safe as Milk or Sugar Water?: Perceptions of Risks and Benefits of the BCG
Vaccine in the 1920s and 1930s in France and Germany. From Danger to Risk:
The Perception and Regulation of X-Rays in Switzerland 1896-1970. The
Population as Patient: Alice Stewart and the Controversy over Low-Level
Radiation in the 1950s. To Treat or Not to Treat: Drug Research and the
Changing Nature of Essential Hypertension. Hormones at Risk: Cancer and the
Medical Uses of Industrially-Produced. Sex Steroids in Germany, 1930-1960.
Assessment and Medical Authority in Operative Fracture Care in the 1960 and
1970s. Assessing the Risk and Safety of the Pill: Maternal Mortality and
the Pill. Addressing Uncertainties: The Conceptualisation of Brain Death in
Switzerland 1960-2000. Risk on Trial. The Interaction of Innovation and
Risk in Cancer Clinical Trials. BioRisk: Interleukin-2 from Laboratory to
Market in the United States and Germany. The Redemption of Thalidomide:
Standardizing the Risk of Birth Defects